Sign In
Buy RVTY
$101.07
+0.680 (+0.677%)
At Close: Jun 03, 2026
Revvity (RVTY) Q2 Earnings Beat Estimates, Guidance Revised
01:21pm, Monday, 29'th Jul 2024
Revvity's (RVTY) second-quarter results showcase a decline in life sciences segmental revenues.
Diagnostic Products Demand Boosts Profit and Sales at Revvity
11:25am, Monday, 29'th Jul 2024
Revvity (RVTY) shares advanced Monday after the medical equipment maker formerly known as PerkinElmer posted better-than-expected results and boosted its profit guidance on higher demand for its diagn
Revvity, Inc. (RVTY) Q2 2024 Earnings Call Transcript
11:23am, Monday, 29'th Jul 2024
Revvity, Inc. (NYSE:RVTY ) Q2 2024 Earnings Conference Call July 29, 2024 8:00 AM ET Company Participants Steve Willoughby - SVP, IR Prahlad Singh - President & CEO Max Krakowiak - SVP & CFO Conferenc
Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Monday, 29'th Jul 2024
The headline numbers for Revvity (RVTY) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Revvity raises 2024 profit forecast on medical equipment demand; shares rise
08:11am, Monday, 29'th Jul 2024
Medical equipment maker Revvity raised its annual profit forecast on Monday, after beating second-quarter results estimates on better-than-expected demand for its diagnostic products.
Revvity (RVTY) Tops Q2 Earnings Estimates
08:10am, Monday, 29'th Jul 2024
Revvity (RVTY) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.21 per share a year ago.
Revvity Announces Financial Results for the Second Quarter of 2024
06:00am, Monday, 29'th Jul 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the second quarter ended June 30, 2024. The Company reported GAAP earnings per share of $0.45, as comp
Analysts Estimate Revvity (RVTY) to Report a Decline in Earnings: What to Look Out for
11:06am, Monday, 22'nd Jul 2024
Revvity (RVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Friday, 19'th Jul 2024
Revvity (RVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now
08:40am, Wednesday, 03'rd Jul 2024
Revvity's (RVTY) strong product portfolio raises optimism about the stock.
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
08:00am, Thursday, 20'th Jun 2024
Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano's VIA™ software to Revvity's next generation sequencing
Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now
12:41pm, Thursday, 30'th May 2024
Revvity's (RVTY) strong product portfolio raises optimism about the stock.
Revvity to Present at Goldman Sachs Global Healthcare Conference
08:00am, Tuesday, 28'th May 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) will present at the 45th Annual Goldman Sachs Global Healthcare Conference on Monday, June 10, 2024 at 8:00 a.m. ET in Miami, FL. Prahlad Si
Lab Instrument Industry Update - New Commercial Entrants
09:17am, Thursday, 23'rd May 2024
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry h
Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates
01:16pm, Monday, 29'th Apr 2024
Revvity's (RVTY) first-quarter results showcase a decline in life sciences segmental revenues. However, the company's earnings and revenues beat their respective estimates.
